Yuan-yuan Qi | Nephrology | Best Researcher Award

Published on by China Scientist

Dr. Yuan-yuan Qi | Nephrology | Best Researcher Award

 Funded Research Projects:

  • Her projects funded by the National Science Foundation of China and the Henan Natural Science Foundation reflect her ability to secure significant grants, demonstrating her research’s importance and potential impact. Additionally, her involvement in the Henan Provincial Talent Training Program indicates her role as a key contributor to innovation in health science and nephrology.
Dr. Yuan-yuan Qi, The First Affiliated Hospital of Zhengzhou University, China

Profile

Scopus

OrcID

🌱EARLY ACADEMIC PURSUITS

  • Yuan-yuan Qi, a distinguished Associate Chief Physician, embarked on her academic journey at Peking University, where she obtained her Ph.D. With a strong foundation in medicine, she quickly demonstrated a passion for research and clinical practice, especially in the field of autoimmune diseases affecting the kidneys.

💼 PROFESSIONAL ENDEAVORS

  • Currently serving at the First Affiliated Hospital of Zhengzhou University, Yuan-yuan Qi holds a crucial role in the Department of Nephrology. Her clinical expertise and research prowess are dedicated to understanding and treating autoimmune kidney diseases, including systemic lupus erythematosus and lupus nephritis. In addition to her role at the hospital, she actively contributes to the Nephrology Physicians’ Association of Henan Province as the Deputy Director of the First Youth Committee and holds a young committee membership in the Henan Renal Pathology Society.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS 

  • Yuan-yuan Qi’s research is highly specialized, focusing on systemic lupus erythematosus, lupus nephritis, and other autoimmune kidney disorders. Her studies delve into the pathophysiology and treatment options for these complex diseases, addressing both clinical and molecular aspects. With a publication record that includes prestigious journals, such as Annals of the Rheumatic Diseases, Arthritis & Rheumatology, and Cell Death & Disease, her work is recognized for its significant impact on the field of nephrology.

 📚 ACADEMIC CITES 

  • The research conducted by Dr. Qi holds substantial weight in the academic realm, with a high citation index that underlines her influence. Her work’s consistent referencing by peers highlights her role in advancing the understanding of nephrology and autoimmune diseases, contributing to both national and international research dialogues.

🌐 PROFESSIONAL MEMBERSHIPS AND LEADERSHIP ROLES

  • Dr. Yuan-yuan Qi holds key positions in prominent nephrology associations, highlighting her leadership within the medical community. She serves as the Deputy Director of the First Youth Committee of the Nephrology Physicians’ Association of Henan Province and is a Young Committee Member of the Henan Renal Pathology Society. These roles reflect her commitment to advancing nephrology, fostering professional growth, and collaborating with other experts to drive innovative research and clinical practices.

🏥 CLINICAL EXPERTISE AND PATIENT-CENTERED CARE

  • As an Associate Chief Physician at the First Affiliated Hospital of Zhengzhou University, Dr. Qi combines her research insights with patient-centered clinical care. She specializes in diagnosing and managing autoimmune kidney diseases, particularly systemic lupus erythematosus and lupus nephritis. Her clinical approach is deeply informed by her research, enabling her to deliver personalized, effective treatments that improve patient outcomes and quality of life.

💰 RESEARCH FUNDING AND GRANT SUPPORT

  • Dr. Qi’s research is well-supported by prestigious funding sources, including the National Science Foundation of China (grant numbers 82470752 and 81900643) and the Henan Natural Science Foundation (grant number 242300421275). She also participates in Henan’s Provincial Talent Training Program for Young and Middle-aged Health and Wellness Science and Technology Innovation (grant number YQRC2024010). These grants underscore her research’s significance, supporting her ongoing work to explore and address autoimmune kidney diseases.

🏆 AWARDS AND RECOGNITIONS

  • Dr. Qi’s contributions have earned her respect and recognition within the nephrology field. Her impactful research and clinical expertise have been acknowledged by her peers, establishing her as an influential voice in nephrology and a leading figure in autoimmune disease research. Through her work, she continues to elevate standards of care and advance knowledge, earning a reputation for excellence in both research and clinical practice.

🌍 IMPACT AND INFLUENCE

  • With 16 SCI-indexed publications as the first or corresponding author, Dr. Qi’s work has amassed over 140 total impact factor points, demonstrating her research’s reach and relevance. Her publications are cited 135 times, reflecting the scientific community’s acknowledgment of her contributions. Her work has advanced knowledge in nephrology, offering insights into autoimmune mechanisms and improving treatment frameworks for patients suffering from severe kidney diseases.

🌟 LEGACY AND FUTURE AND CONTRIBUTIONS

  • Dr. Qi’s ongoing research and commitment to innovation position her as a forward-thinking leader in nephrology. Through her involvement in projects funded by the National Science Foundation of China, the Henan Natural Science Foundation, and Henan’s Young and Middle-aged Talent Training Program, she continues to push the boundaries of nephrology research. Her future work promises further contributions to the understanding of autoimmune kidney diseases, enhancing treatment protocols and patient outcomes.

📄Publications

  • Unveiling biomarkers and therapeutic targets in IgA nephropathy through large-scale blood transcriptome analysis
    Authors: Gan, T., Qu, L.-X., Qu, S., Peng, Y.-J., Zhou, X.-J.
    Journal: International Immunopharmacology, 2024, 132, 111905
  • A cluster of type I interferon-regulated genes associates with disease activity and prognosis in patients with IgA nephropathy
    Authors: Qu, S., Gan, T., Wang, Y.-N., Zhang, H., Zhou, X.-J.
    Journal: International Immunopharmacology, 2024, 131, 111920
  • Clinical features and prognosis of patients with anti-GBM disease combined with mesangial IgA deposition
    Authors: Ning, W., Zhao, Y.-F., Liu, Y.-R., Qi, Y.-Y., Zhao, Z.-Z.
    Journal: Frontiers in Immunology, 2024, 15, 1373581
  • KLF2 enhancer variant rs4808485 increases lupus risk by modulating inflammasome machinery and cellular homoeostasis
    Authors: Singh, M.K., Rallabandi, H.R., Zhou, X.-J., Looger, L.L., Nath, S.K.
    Journal: Annals of the Rheumatic Diseases, 2024, ard-2023-224953
  •  SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy
    Authors: Zhao, X.-Y., Li, S.-S., He, Y.-X., Li, Y.-C., Qi, Y.-Y.
    Journal: Annals of the Rheumatic Diseases, 2023, 82(10), pp. 1328–1340

Min Zhang | Nephrology | Best Researcher Award

Published on by China Scientist

Dr. Min Zhang | Nephrology | Best Researcher Award

 Cutting-Edge Research:

  • Dr. Zhang is at the forefront of nephrology research, focusing on disease mechanisms using multi-omics technology. Her ongoing projects, funded by major institutions like the National Natural Science Foundation of China, demonstrate her capability to secure competitive grants and her engagement with high-impact research.
Dr. Min Zhang, Department of Nephrology, First Medical Center of Chinese PLA General Hospital, China

Profile

Scopus

OrcID

🌱EARLY ACADEMIC PURSUITS

  • Dr. Min Zhang began her academic journey at the prestigious Tongji Medical College of Huazhong University of Science and Technology, where she earned her bachelor’s degree. She later pursued her doctoral studies at the Academy of Military Sciences, focusing on leveraging multi-omics technology to explore disease mechanisms. Her exemplary work earned her the Outstanding Doctoral Dissertation of the PLA award, a mark of distinction that set the foundation for her impactful career.

💼 PROFESSIONAL ENDEAVORS

  • Currently serving as an Attending Physician in the Department of Nephrology at the First Medical Center of Chinese PLA General Hospital, Dr. Zhang is committed to advancing nephrology and disease research through innovative approaches like single-cell sequencing. She has also been recognized as a young talent in China’s Association for Science and Technology’s Talent Lifting Program, an acknowledgment of her potential and early career achievements.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS 

  • Dr. Zhang has published 19 SCI-indexed papers across reputable journals, such as GUT, Journal of Hepatology, Science Advances, and Molecular Therapy. Her research spans nephrology and single-cell sequencing, with a specific focus on applying multi-omics technology to understand disease development and progression. With 8 first-author papers and 5 co-corresponding author papers, she has become a leading voice in her field, contributing to groundbreaking insights in disease biology.

 📚 ACADEMIC CITES 

  • Dr. Zhang’s research excellence is reflected in multiple awards, including the Beijing Natural Science Award (second prize) and accolades for her dissertation work. She has also been named a Youth Member of the Smart Medical Professional Committee of the Chinese Association of Integrative Medicine, enhancing her profile as a respected thought leader in innovative medical research.

🌍 IMPACT AND INFLUENCE

  • Dr. Zhang’s work has garnered significant attention, with her research cited 850 times overall and her highest-cited paper receiving 360 citations. Notably, her contributions include 3 ESI highly cited papers and 1 F1000 recommended paper, underscoring her work’s influence within the scientific community. Her ability to address complex medical challenges has positioned her as a key contributor to both nephrology and integrative medical research.

🌟 LEGACY AND FUTURE AND CONTRIBUTIONS

  • Looking ahead, Dr. Zhang aims to deepen her contributions to nephrology through advanced, single-cell sequencing approaches and multi-omics studies. Her ongoing and completed research projects, including those funded by the National Natural Science Foundation of China (Grant No. 82203636) and the Young Talent Project of Chinese PLA General Hospital (20230403), highlight her commitment to tackling complex nephrological issues and contributing to the future of medical science.

📄Publications

  • “Comparison of preparation methods of rat kidney single-cell suspensions”
    Authors: Wang, T., Shen, W., Li, L., … Zhang, M., Chen, X.
    Journal: Scientific Reports, 2024, 14(1), 2785
  • “Highlighting immune features of the tumor ecosystem and prognostic value of Tfh and Th17 cell infiltration in head and neck squamous cell carcinoma by single-cell RNA-seq”
    Authors: Tian, Y., Liu, C., Yang, W., … Qin, Y., Wu, S.
    Journal: Cancer Immunology, Immunotherapy, 2024, 73(10), 187
  • “Treatment strategies with combined agency against severe viral pneumonia in patients with advanced cancer”
    Authors: Zhang, F., Li, T., Bai, Y., … Tao, H., Hu, Y.
    Journal: Journal of Translational Internal Medicine, 2024, 12(3), pp. 317–320
  • “Enhanced TRPC3 transcription through AT1R/PKA/CREB signaling contributes to mitochondrial dysfunction in renal tubular epithelial cells in D-galactose-induced accelerated aging mice”
    Authors: Wang, B., Yu, W., Zhang, W., … Chen, X., Chen, Y.
    Journal: Aging Cell, 2024, 23(6), e14130
  • “Cross-species single-cell analysis uncovers the immunopathological mechanisms associated with IgA nephropathy progression”
    Authors: Chen, X., Wang, T., Chen, L., … Zhang, M., Chen, X.
    Journal: JCI Insight, 2024, 9(9), e173651